This technology concerns an RNA interference-inducing nucleic acid that inhibits off-target genes of microRNA by modifying a portion of a specific microRNA's sequence.
Conventional microRNAs regulate both on-target and off-target interactions, which presented a limitation in selectively inducing only desired biological functions.
The RNAi-inducing nucleic acid of this technology can selectively enhance and induce functions that arise from off-target inhibition. This allows for its application in diverse fields, including pharmaceuticals and cosmetics, for regulating processes such as cell cycle, differentiation, migration, proliferation, and apoptosis.
CN112601817A, EP3822350A1, JP2022-141687A, JP7432929B2, US2022-0267766A1